Literature DB >> 29749106

Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker.

Caroline Gjestad1, Tore Haslemo1, Ole A Andreassen2,3, Espen Molden1,4.   

Abstract

Entities:  

Keywords:  4β-hydroxycholesterol; CYP3A4; quetiapine

Mesh：

Substances：

Year:  2018        PMID： 29749106      PMCID： PMC6005591          DOI： 10.1111/bcp.13606

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

1.  Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.

Authors:  Angela K Goodenough; Joelle M Onorato; Zheng Ouyang; Shu Chang; A David Rodrigues; Sreeneeranj Kasichayanula; Shu-Pang Huang; Wesley Turley; Richard Burrell; Marc Bifano; Mohammed Jemal; Frank LaCreta; Adrienne Tymiak; David Wang-Iverson
Journal:  Chem Res Toxicol       Date:  2011-07-21       Impact factor: 3.739

2.  Impact of genetic and nongenetic factors on interindividual variability in 4β-hydroxycholesterol concentration.

Authors:  Kristine Hole; C Gjestad; K M Heitmann; T Haslemo; E Molden; S Bremer
Journal:  Eur J Clin Pharmacol       Date:  2016-12-14       Impact factor: 2.953

3.  Recovery of CYP3A Phenotype after Kidney Transplantation.

Authors:  Kristine Hole; Elisabet Størset; Ane Olastuen; Tore Haslemo; Grete Birkeland Kro; Karsten Midtvedt; Anders Åsberg; Espen Molden
Journal:  Drug Metab Dispos       Date:  2017-09-19       Impact factor: 3.922

4.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters.

Authors:  Stephen Ph Alexander; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

5.  Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

Authors:  Sibylle Neuhoff; Geoffrey T Tucker
Journal:  Br J Clin Pharmacol       Date:  2018-02-21       Impact factor: 4.335

6.  Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker.

Authors:  Caroline Gjestad; Tore Haslemo; Ole A Andreassen; Espen Molden
Journal:  Br J Clin Pharmacol       Date:  2018-05-10       Impact factor: 4.335

7.  CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels.

Authors:  F Josephson; L Bertilsson; Y Böttiger; L Flamholc; M Gisslén; V Ormaasen; A Sönnerborg; U Diczfalusy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-06       Impact factor: 2.953

8.  4β-hydroxycholesterol correlates with dose but not steady-state concentration of carbamazepine: indication of intestinal CYP3A in biomarker formation?

Authors:  Caroline Gjestad; Duy Khanh Huynh; Tore Haslemo; Espen Molden
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

9.  Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric?

Authors:  D Tomalik-Scharte; D Lütjohann; O Doroshyenko; D Frank; A Jetter; U Fuhr
Journal:  Clin Pharmacol Ther       Date:  2009-05-20       Impact factor: 6.875

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971
View more
  3 in total

1.  Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol-an Interaction Study in Healthy Volunteers.

Authors:  Caroline Gjestad; Kristine Hole; Tore Haslemo; Ulf Diczfalusy; Espen Molden
Journal:  AAPS J       Date:  2019-04-24       Impact factor: 4.009

2.  Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker.

Authors:  Caroline Gjestad; Tore Haslemo; Ole A Andreassen; Espen Molden
Journal:  Br J Clin Pharmacol       Date:  2018-05-10       Impact factor: 4.335

3.  Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.

Authors:  Kine Eide Kvitne; Kristine Hole; Veronica Krogstad; Birgit Malene Wollmann; Christine Wegler; Line K Johnson; Jens K Hertel; Per Artursson; Cecilia Karlsson; Shalini Andersson; Tommy B Andersson; Rune Sandbu; Jøran Hjelmesæth; Eva Skovlund; Hege Christensen; Rasmus Jansson-Löfmark; Anders Åsberg; Espen Molden; Ida Robertsen
Journal:  Eur J Clin Pharmacol       Date:  2022-06-01       Impact factor: 3.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.